Survey of treatment practices for immunocompromised patients with COVID-19 in Australasia.

Michael A Moso, Joe Sasadeusz, Catherine O Morrissey, Katherine Bond, Stephen Guy, Monica A Slavin, Claire Dendle

Internal medicine journal 2023 Apr

filter terms:

australasia (3)

humans (1)

patients (3)

questionnaires (1)

Sizes of these terms reflect their relevance to your search.

Coronavirus disease 2019 (COVID-19) in immunocompromised patients can lead to severe and prolonged illness. Data are limited with regard to management of COVID-19 in this setting, particularly in persistent or recrudescent infection. The authors conducted an online survey among infectious diseases doctors to determine current approaches to treatment across Australasia. There was marked variability in responses relating to the diagnostic modalities and use of antiviral agents in patients with immunocompromise, highlighting the need for high-quality studies to guide treatment decisions in this group. © 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.

Citation

Michael A Moso, Joe Sasadeusz, Catherine O Morrissey, Katherine Bond, Stephen Guy, Monica A Slavin, Claire Dendle. Survey of treatment practices for immunocompromised patients with COVID-19 in Australasia. Internal medicine journal. 2023 Apr;53(4):619-624